Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Corporate Update
MGC Pharmaceuticals Ltd (ASX: MXC or "the Company") advises the Company's Board and independent committees have, following the recent dual listing on the London Stock Exchange, and in conjunction with the Company's key advisors in the United Kingdom, agreed market appropriate changes to the remuneration and equity incentive structures of the Executive Directors and Key Management Personnel. This includes a new performance rights program structured to retain the services of key personnel managing the Company's business and to bring in line with similar listed ...
Source: investegate.co.uk